Also known as Sensory Hearing Loss and Sensorineural Deafness
Sensorineural hearing loss (SNHL) is a type of hearing loss in which the root cause lies in the vestibulocochlear nerve (cranial nerve VIII), the inner ear, or central processing centers of the brain. Sensorineural hearing loss can be mild, moderate, or severe, including total deafness.Source: Wikipedia
Within all the people who go to their doctor with sensorineural hearing loss, 90% report having diminished hearing, 57% report having plugged feeling in ear, and 49% report having ringing in ear. The symptoms that are highly suggestive of sensorineural hearing loss are diminished hearing, plugged feeling in ear, ringing in ear, and itchy ear(s), although you may still have sensorineural hearing loss without those symptoms.
Patients with sensorineural hearing loss often receive ophthalmologic and otologic diagnosis and treatment, magnetic resonance imaging, other diagnostic procedures (interview; evaluation; consultation), other therapeutic ear procedures, psychological and psychiatric evaluation and therapy, tracheoscopy and laryngoscopy with biopsy, diagnostic procedures on nose; mouth and pharynx and other or therapeutic procedures on nose; mouth and pharynx .
|Ophthalmologic and otologic diagnosis and treatment||$64|
|Magnetic resonance imaging (Mri)||$297|
|Other diagnostic procedures (interview; evaluation; consultation)||$101|
|Other therapeutic ear procedures||$714|
|Psychological and psychiatric evaluation and therapy||$120|
|Tracheoscopy and laryngoscopy with biopsy||$246|
|Diagnostic procedures on nose; mouth and pharynx||$96|
|Other OR therapeutic procedures on nose; mouth and pharynx||$1509|
The most commonly prescribed drugs for patients with sensorineural hearing loss include mometasone nasal product, azelastine nasal, fluocinolone otic, chlorthalidone, ubiquinone (q10), oxazepam, tiagabine (gabitril), trandolapril, levocarnitine, potassium citrate, bendroflumethiazide / nadolol, brompheniramine / pseudoephedrine and flurbiprofen ophthalmic product .
Groups of people at highest risk for sensorineural hearing loss include age 75+ years age 60-74 years.